Galecto

3 followers

‌

Galecto is a clinical-stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.

Industries

Biotechnology

Headquarters

København, Denmark

Employees

11-50

Links

Org chart

Hans T. Schambye

President & CEO

Hans T. Schambye

Collapse

Tariq Sethi

Co-Founder

Garrett Winslow

General Counsel, Corporate Secretarty

Frank L.

Global SVP (China medical information public opinion security)

Rob Slack, FRSB

Vice President & Head of Pharmacology

Becky Smith

Interim Project Leader

Lori C. Firmani, CPA, MBA

VP of Finance

Zahir Rajiwate

Director, Clinical Operations & Data Management

Teams

Directors and Vice Presidents

8 members

Leadership Team

4 members

Offices

Similar companies

Synthekine

3 followers

Caribou Biosciences

2 followers

Vera Therapeutics

2 followers

Neogene Therapeutics

2 followers

Kyverna Therapeutics

7 followers

Day One Biopharmaceuticals

1 follower

Isotopen Technologien München

1 follower

Aura Biosciences

1 follower

CG Oncology

1 follower

Aviceda Therapeutics

1 follower

Foresight Diagnostics

1 follower

Explore companies